We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA issued a final rule on “Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices” (21 CFR Part 99) in the Nov. 20, 1998, Federal Register.